Showing results (261-270 of 302) with videos related to
Sort By:
Pageof 31
Cell Stem Cell|February 2, 2021
Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genesParisha P Shah, Wenjian Lv, Joshua H Rhoades, et al.Nature|November 15, 2019
Author Correction: Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.Hypertension (Dallas, Tex. : 1979)|May 20, 2026
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191Bonnie Ky, Tao Liu, Kenneth B Margulies, et al.Nature|September 13, 2019
Targeting cardiac fibrosis with engineered T cellsHaig Aghajanian, Toru Kimura, Joel G Rurik, et al.Research Square|December 4, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.Circulation Research|June 13, 2020
Epigenomes of Human Hearts Reveal New Genetic Variants Relevant for Cardiac Disease and PhenotypeWilson Lek Wen Tan, Chukwuemeka George Anene-Nzelu, Eleanor Wong, et al.Nature Cardiovascular Research|June 5, 2025
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Michelle Youlton, et al.The Journal of Clinical Investigation|February 20, 2018
A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortalityXiaoming Zhang, Jin-Young Yoon, Michael Morley, et al.Nature Medicine|February 14, 2017
Sirtuin 1 regulates cardiac electrical activity by deacetylating the cardiac sodium channelAjit Vikram, Christopher M Lewarchik, Jin-Young Yoon, et al.Pageof 31